Ventas, Inc. (NYSE:VTR) has been given a consensus recommendation of “Hold” by the seventeen ratings firms that are currently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $59.33.
VTR has been the topic of several analyst reports. KeyCorp set a $55.00 target price on Ventas and gave the company a “sell” rating in a report on Thursday, December 20th. Zacks Investment Research cut Ventas from a “hold” rating to a “sell” rating in a report on Monday, December 31st. BMO Capital Markets upped their target price on Ventas from $60.00 to $62.00 and gave the company a “market perform” rating in a report on Monday, February 11th. Morgan Stanley initiated coverage on Ventas in a report on Thursday, March 28th. They issued an “equal weight” rating and a $61.00 target price on the stock. Finally, Deutsche Bank upped their target price on Ventas from $54.00 to $57.00 and gave the company a “hold” rating in a report on Friday, March 29th.
In related news, CFO Robert F. Probst sold 10,000 shares of the stock in a transaction on Friday, February 15th. The stock was sold at an average price of $65.01, for a total value of $650,100.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director James D. Shelton sold 5,940 shares of the stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $64.79, for a total value of $384,852.60. Following the completion of the transaction, the director now owns 46,860 shares in the company, valued at $3,036,059.40. The disclosure for this sale can be found here. Insiders have sold a total of 107,464 shares of company stock worth $6,900,138 over the last 90 days. Company insiders own 1.40% of the company’s stock.
VTR stock traded down $0.71 during trading on Thursday, hitting $61.89. The company had a trading volume of 1,575,940 shares, compared to its average volume of 2,086,599. Ventas has a one year low of $46.55 and a one year high of $65.70. The stock has a market capitalization of $22.37 billion, a PE ratio of 15.21, a PEG ratio of 3.26 and a beta of 0.32. The company has a debt-to-equity ratio of 1.04, a current ratio of 0.53 and a quick ratio of 0.53.
Ventas (NYSE:VTR) last announced its earnings results on Friday, February 8th. The real estate investment trust reported $0.96 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.01. Ventas had a return on equity of 3.54% and a net margin of 10.93%. The business had revenue of $923.26 million for the quarter, compared to analysts’ expectations of $913.92 million. During the same period in the prior year, the business posted $1.03 earnings per share. The firm’s revenue was up 3.1% on a year-over-year basis. As a group, research analysts expect that Ventas will post 3.81 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 12th. Shareholders of record on Monday, April 1st will be issued a dividend of $0.7925 per share. This represents a $3.17 dividend on an annualized basis and a dividend yield of 5.12%. The ex-dividend date is Friday, March 29th. Ventas’s payout ratio is 77.89%.
Ventas Company Profile
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Further Reading: Do You Need a Fiduciary?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.